Generalised muscle weakness after bladder wall injection of Abobotulinum Toxin A: experience of a woman with tetraplegia who required increased caregiver support: importance of doctor–patient communication: duty of candour for spinal cord physician and responsibilities of a patient-Reference-Cited by-同舟云学术

Generalised muscle weakness after bladder wall injection of Abobotulinum Toxin A: experience of a woman with tetraplegia who required increased caregiver support: importance of doctor–patient communication: duty of candour for spinal cord physician and responsibilities of a patient

Published:2018-11-13 Issue:1 Volume:4 Page:
ISSN:2058-6124
Container-title:Spinal Cord Series and Cases
language:en
Short-container-title:Spinal Cord Ser Cases

Author:

Vaidyanathan Subramanian,Foster Tracey,Soni Bakul M.

Publisher

Springer Science and Business Media LLC

Subject

Dermatology,Neurology

Link

http://www.nature.com/articles/s41394-018-0128-x.pdf

Reference20 articles.

1. Peyronnet B, Roumiguié M, Castel-Lacanal E, Guillotreau J, Marque P, Rischmann P, et al. Efficacy and safety of the first and repeated intradetrusor injections of abobotulinum toxin A 750 U for treating neurological detrusor overactivity. World J Urol. 2016;34:755–61. https://doi.org/10.1007/s00345-015-1666-5 . Epub 2015 Aug 18

2. Grosse J, Kramer G, Jakse G. Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: a case-control study. BJU Int. 2009;104:651–6. https://doi.org/10.1111/j.1464-410X.2009.08466.x . Epub 2009 Mar 5

3. Patki PS, Hamid R, Arumugam K, Shah PJ, Craggs M. Botulinum toxin-type A in the treatment of drug-resistant neurogenic detrusor overactivity secondary to traumatic spinal cord injury. BJU Int. 2006;98:77–82.

4. Del Popolo G, Li Marzi V, Panariello G, Lombardi G. English botulinum toxin A in the treatment of neurogenic detrusor overactivity. Neurourol Urodyn. 2003;22:498–9.

5. Cheng T, Shuang WB, Jia DD, Zhang M, Tong XN, Yang WD, et al. Efficacy and safety of onabotulinumtoxin A in patients with neurogenic detrusor overactivity: a systematic review and meta-analysis of randomized controlled trials. PLoS ONE. 2016;27:e0159307 https://doi.org/10.1371/journal.pone.0159307 .

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toxina botulínica en el tratamiento de la hiperactividad vesical neurógena y no neurológica;EMC - Urología;2024-03

2. Systemic muscular weakness after botulinum toxin A administration: a review of the literature;Drugs & Therapy Perspectives;2021-05-31